|
| Volume 28(1); February 2025 |
| Original Articles |
1 |
The Incidence of Occult Malignancy in Contralateral Risk Reducing Mastectomy Among Affected Breast Cancer Gene Mutation Carriers in South Korea
Lee CE, Shin DS, Kim KJ, Nam SJ, Kim SW, Yu J, Chae BJ, Lee SK, Ryu JM, Mun GH, Pyon JK, Jeon BJ, Woo K, Lee JE. |
11 |
Impact of HER2-Low Status on Pathologic Complete Response and Survival Outcome Among Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Lee YJ, Yoo TK, Lee SB, Chung IY, Kim HJ, Ko BS, Lee JW, Son BH, Ahn SH, Jeong H, Jung JH, Ahn JH, Jung KH, Kim SB, Lee HJ, Gong G, Kim J. |
23 |
Differences in HER2-0 and HER2-low Breast Cancer: Androgen Receptor and Programmed Death Ligand 1 as Predictive Factors
Zhang X, Yang C, Chen Y, Zhang J, Li P, Huang N, Chen Y, Liang M, Lv W, Yuan Z, Li J, Wang K. |
| Brief Communication |
37 |
Treatment Patterns and Outcomes of Young Female Early Breast Cancer in Taiwan
Huang CC, Tseng LM. |
| Letters to the Editor |
46 |
Letter to the Editor: “Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer”
Bergmann A, de Andrade MF. |
48 |
Reply to “Letter to the Editor: Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer”
Byeon J, Kang E, Jung JJ, Cheun JH, Seo KS, Kim HK, Lee HB, Han W, Moon HG. |
| |
|
|
